25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population

scientific article

25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5414/CN108365
P932PMC publication ID4535176
P698PubMed publication ID25208315

P50authorKristen L NowakQ48040892
P2093author name stringJessica Kendrick
Michel Chonchol
Alfred K Cheung
Anna J Jovanovich
Christopher B Brady
James D Kaufman
P2860cites workCKD associates with cognitive declineQ33561710
Vitamin D and neurocognitive dysfunction: preventing "D"ecline?Q33693884
Vitamin D and risk of cognitive decline in elderly personsQ33742161
Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive studyQ33782286
Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormoneQ34461127
25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adultsQ34485935
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trialQ34582863
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine studyQ34610179
FGF-23 and cognitive performance in hemodialysis patientsQ35647125
Cognitive function in dialysis patientsQ36064895
Association between serum 25(OH) vitamin D and the risk of cognitive decline in older womenQ36222215
Psychiatric and cognitive aspects of primary hyperparathyroidismQ36667650
Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patientsQ36910962
Genes, endothelial function and cerebral small vessel disease in man.Q36969770
Cognitive function in chronic kidney diseaseQ37077771
Neuropsychological features in primary hyperparathyroidism: a prospective studyQ37212298
Detection of early dementia in the elderlyQ41170944
Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23.Q42492760
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney diseaseQ42976674
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemiaQ44414604
Biological variability of plasma intact and C-terminal FGF23 measurementsQ45399588
Endothelial dysfunction associated with mild cognitive impairment in elderly population.Q45480945
Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly.Q46549782
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) studyQ46797792
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø studyQ46800287
No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III.Q46979586
Subclinical vascular disease of the brain in dialysis patientsQ48126601
The brain and the kidney connection: A model of accelerated vascular cognitive impairmentQ48481040
Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot studyQ48495225
Role of uremia, brain calcium, and parathyroid hormone on changes in electroencephalogram in chronic renal failureQ48673023
Cerebral small-vessel disease and decline in information processing speed, executive function and memoryQ48860735
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men.Q50744694
Characteristics of two telephone screens for cognitive impairment.Q51958962
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.Q53224110
Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patientsQ61853240
Prevalence, recognition, and implications of mental impairment among hemodialysis patientsQ73491855
Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiencyQ79485416
The cognition-kidney disease connection: lessons from population-based studies in the United StatesQ81669064
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studiesQ83418512
P433issue5
P921main subjectvitamin DQ175621
veteranQ193891
P304page(s)S1-4
P577publication date2014-11-01
P1433published inClinical NephrologyQ15763520
P1476title25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population
P478volume82

Reverse relations

cites work (P2860)
Q98293278Association Between Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study
Q26748967Role of Vitamin D in Cognitive Function in Chronic Kidney Disease
Q40281627Serum phosphate and cognitive function in older men.
Q88868593The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review
Q36182304Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study.

Search more.